“Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways” (2006) Journal of Carcinogenesis, 5(1). Available at: https://carcinogenesis.com/index.php/JOC/article/view/227 (Accessed: 7 December 2025).